ONCOLOGY CLINICAL TRIALS: SUCCESSFUL DESIGN, CONDUCT, AND ANALYSIS, 2ND EDITION
Statistical Considerations for Developing and Validating Prognostic Models of Clinical Outcomes
Publication
, Chapter
Halabi, S; Pi, L
2018
Duke Scholars
ISBN
978-0-8261-6872-6
Publication Date
2018
Start / End Page
313 / 322
Citation
APA
Chicago
ICMJE
MLA
NLM
Halabi, S., & Pi, L. (2018). Statistical Considerations for Developing and Validating Prognostic Models of Clinical Outcomes. In ONCOLOGY CLINICAL TRIALS: SUCCESSFUL DESIGN, CONDUCT, AND ANALYSIS, 2ND EDITION (pp. 313–322).
Halabi, Susan, and Lira Pi. “Statistical Considerations for Developing and Validating Prognostic Models of Clinical Outcomes.” In ONCOLOGY CLINICAL TRIALS: SUCCESSFUL DESIGN, CONDUCT, AND ANALYSIS, 2ND EDITION, 313–22, 2018.
Halabi S, Pi L. Statistical Considerations for Developing and Validating Prognostic Models of Clinical Outcomes. In: ONCOLOGY CLINICAL TRIALS: SUCCESSFUL DESIGN, CONDUCT, AND ANALYSIS, 2ND EDITION. 2018. p. 313–22.
Halabi, Susan, and Lira Pi. “Statistical Considerations for Developing and Validating Prognostic Models of Clinical Outcomes.” ONCOLOGY CLINICAL TRIALS: SUCCESSFUL DESIGN, CONDUCT, AND ANALYSIS, 2ND EDITION, 2018, pp. 313–22.
Halabi S, Pi L. Statistical Considerations for Developing and Validating Prognostic Models of Clinical Outcomes. ONCOLOGY CLINICAL TRIALS: SUCCESSFUL DESIGN, CONDUCT, AND ANALYSIS, 2ND EDITION. 2018. p. 313–322.
ISBN
978-0-8261-6872-6
Publication Date
2018
Start / End Page
313 / 322